F. Ramos

CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.

E. Giné, S. Rives, J. Esteve, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Short-term safety of mTOR inhibitors in infants and very young children with tuberous sclerosis complex (TSC): Multicentre clinical experience.

O. Devinsky, V. Narayanan, S. Jóźwiak, 2018, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Neuromuscular Manifestations in Mitochondrial Diseases in Children.

C. Ortez, M. O'Callaghan, À. García‐Cazorla, 2016, Seminars in pediatric neurology.

GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction

F. Villarroya, S. Kalko, E. Ruiz-Pesini, 2016, PloS one.

Secondary coenzyme Q10 deficiencies in oxidative phosphorylation (OXPHOS) and non-OXPHOS disorders.

P. Navas, E. Ruiz-Pesini, E. Trevisson, 2016, Mitochondrion.

Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders

J. Armstrong, A. Ormazabal, R. Artuch, 2015, Orphanet Journal of Rare Diseases.

Okur‐Chung neurodevelopmental syndrome in a patient from Spain

C. Arjona, A. García-Alix, A. Martínez-Monseny, 2019, American journal of medical genetics. Part A.

Evolution of maple syrup urine disease in patients diagnosed by newborn screening versus late diagnosis.

M. Couce, Á. García-Cazorla, A. Fernández-Marmiesse, 2015, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

Discovery of Biomarker Panels for Neural Dysfunction in Inborn Errors of Amino Acid Metabolism

J. Armstrong, A. Ormazabal, R. Artuch, 2019, Scientific Reports.

Discovery of Biomarker Panels for Neural Dysfunction in Inborn Errors of Amino Acid Metabolism

J. Armstrong, A. Ormazabal, R. Artuch, 2019, Scientific Reports.